White House Reviews CMS Plan For Drug Pricing Demos; CMS, Drug Makers To Meet Second Time On IRA

By Gabrielle Wanneh / January 23, 2023 at 4:49 PM
The White House is reviewing a closely held CMS plan to launch innovation center demonstrations to lower drug prices. CMS also will powwow with drug makers Tuesday (Jan. 24) in a second meeting to discuss implementation of ground-breaking drug-pricing provisions in the Inflation Reduction Act, specifically recent inflation rebate guidance in relation to the 340B drug discount program, agency officials tell Inside Drug Pricing. The CMS innovation center last week sent the White House a report listing multiple demonstration...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.